Personal Information:


Name: Reza


Last name: Khodabakhshi


Gender: Male


Marital Status: Married Nationality: Iranian


Date of birth: 7.JAN. 1969 Present Position:


1)Radiation Oncologist Consultant, Onco-geriatric


2) Direct Manager of Shafa Teb K Co


3) UICC Fellow & Reviewer




1. Radiation Oncology Department, Shahid Fayaz Bakhsh Hospital, (Social Security Organization affiliated) 7th km of Old Karaj Road ,Tehran ,Iran


2. Radiation Oncology Department, Boali Hospital (AUMS) Damavand St Tehran .Iran


Mobile phone: +98-912 199 1557


Telfax: +98-21-3325 0495


Email: این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید


این آدرس ایمیل توسط spambots حفاظت می شود. برای دیدن شما نیاز به جاوا اسکریپت دارید






1) PARIS VI UNIVERSITY: AFSA(Medical Oncology and Onco-geriatric)


DIU Onco-geriatric (Nov2007-Nov2008)


2) UICC Fellowship : Stereotactic Raditherapy in Brain Tumor ;


Royal Marsden Hospital ,London ,UK(Nov 2003)


3) SHAHID BEHESHTI UIVERSITY OF MEDICAL SCIENCES- Radiation Oncology Board Certified (Second Position in National Board Examination) Tehran – Iran (1996-2000)


Third Position in Pre-board examination


4) GILAN UNIVERSITY OF MEDICAL SCIENCE General Physician–Rasht -Iran(1986-1993)




1) SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCE Research Methodology Workshop,(1week)1999


3) Brachytherapy Workshop, EMAM Hossien Hospital,Tehran Iran (Nov 1999)




Medical Paper Preparing–Tehran (2001) (3 DAY)


4) National Training Course on Medical Preparedness and Response to Radiation Emergencies Part 1 (IAEA,NOVIN ,M,I.AEOI)Tehran ,Iran ,2-6,Oct,2004


5) National Training course on Radiation Protection and Radiotherapy, Part 2 (IAEA,AEOI,Novin Medical Institute)Tehran ,Iran,5-9 March 2005


6) IMRT Course, Heidelberg ,Germany,March,2006




1) Comparison of the Performance of Log-logistic Regression and Artificial Neural Networks for Predicting Breast Cancer Relapse: Asian Pac J Cancer Prev. 2014;15(14):5883-8


2) Survival analysis of patients with adenocarcinoma gastric cancer in Fayaz Bakhsh Hospital Tehran ,Razi Journal of Medical Sciences Vol. 21, No.123,Aug-Sep 2014


3)Attitude of cancer patients toward diagnosis disclosure and their preference for clinical decision-making: a national survey. Arch Iran Med. 2014 Apr;17(4):232-


40. doi: 014174/AIM.004.


4)The impact of multiple recurrences in disease-free survival of breast cancer: an extended Cox model. Tumori. 2012 Jul-Aug;98(4):428-33. doi:




5) Artificial Neural Network for Prediction of Distant Metastasis in Colorectal Cancer; Asian Pcific J Cancer Prev,2012;13(3);927-930


6) Recurrence in Breast Cancer; the Razi Journal of Medical Sciences - Vol. 18, No. 89


7)Factors leading oncologists to refer elderly cancer patients for geriatric assessment; Journal of Geriatric Oncology Vol. 2, Issue 3, Pages 194-199, 2011


8) Comparison of three adjuvant chemotherapy regimens using an extended log-


logistic model in women with operable breast cancer. Asian Pac J Cancer Prev.




9) Treatment and prognosis of ovarian cancer; Five years multi center study: Saudi Med J 2008, Dec 22(29)1735-8


10) McGill Quality of Life Questionnaire: Reliability and Validity of the Persian Version in Iranian Patients with Advanced Cancer:


Journal of PalliativeMedicine; Volume 11, Number 4, 2008


11) Pediatric Cancers that need radiotherapy in Iran: 30 years of one hospital data analysis, Iranian Journal of Cancer Prevention Vol.1, No.1, 17-22, 2008. Jan


12) Truth- telling to cancer patients from relative point of view: a multicenter study in Iran: Austral - Asian Journal of Cancer, Vol. 6, No.4, October 2007 pp213-217


13) Quality of Sleep in Cancer Patients: Evidences from Persian Translation of Pittsburgh Sleep Quality Index: Austral -Asian Journal of Cancer, Vol. 6, No.3, July 2007 PP: 165 – 168


14) Descriptive epidemiology and prognostic factors in gastric cancer at Tehran .Iran. Medical Social Security journal, 6th Year, Dec. 2006 – Mar. 2007 PP: 79 – 86


15) Heterogeneity in Disease-Free Survival in Breast Cancer Patients,


Journal of Clinical Oncology, 2007 ASCO Annual Meeting,


Vol. 25, June 20th 2007: 11106


16) Treatment and Prognosis of Epithelial Ovarian Cancer in Iran,


Journal of Clinical Oncology, 2007 ASCO Annual Meeting,


Vol. 25, June 20th 2007: 5586


17) Clinic-pathological Features of Primary Central Nervous System Lymphoma; Neurosciences 2006; Vol.11 (4);284-288


18) Erb-B2 And P53 Expression as Predictive Factors in High-Grade Osteosarcoma;Cancer Bulletin of the Cancer Institute of Iran,Vol1(1),Spring 2006:pp45-50


19) Recurrence in breast cancer. Analysis with frailty model, Saudi Med J. 2006 Aug;27(8):1187-93


20) Reproductive Characteristics and the Risk of Breast Cancer: A case-Control Study: Iranian Journal of Epidemiology, Vol, 1(2) Winter2006


21) Disease-Free Survival and Metastasis Pattern in Breast Cancer Patients after Mastectomy: An application of Stratified Markove Model: International journal of Cancer Research 2(1):10-18, 2006


22) Prevention of TA-GVHD by Irradiation of Blood Products (review of articles) Medical Social Security Journal,4th year ,Dec 2004pp:24-27


23) 99m TC-DMSA Renal Scan for Localization and Renal Shielding in Radiotherapy; Iranian Journal of Nuclear Medicine; Vol, 12, 13 (2000) pp21-26


24) Book Translation (ENGLISH TO PERSIAN ) Author: Kefah.M.Mokbel (1999)






1-Raditherapy in Benign Disease– ISRO (Iranian Society of radiotherapeutic oncology) monthly lecture 2000 Tehran – Iran 2-Report of 2064 of Skin Cancer: (Poster) First International Iranian congress on cancer 11-13 Sept, 2001, Mashhad ,Iran
3-Irradiation and Chemoirradiation of Lung :Nuclear medicine and oncology congress May 2002 – RASHT- IRAN
4-Radiotherapy In Thyroid Cancer: Nuclear medicine and oncology congress May 2002, RASHT IRAN
5-Treatment of Wilms Tumor: 26
th congress of Iranian association of surgeon –ISRO annual congress,12-16 May 2002, Tehran, Iran


6-Manegment of Met static Prostate Cancer: 28th congress of Iranian association of surgeon 12-16 May 2004, Tehran,Iran


7-Descriptive Epidemiology and Prognostic Factors in Gastric Cancer at Fayazbahsh


Hospital, Tehran , Iran(Oral Presentation )the 3rd Regional Conference Of Asian


Organization For cancer Prevention (APOCP) Zibakenar, Iran,April25-27,2005 8-C-erbB2 and P53 Expressions Predictive factor in High Grade Osteosarcoma(Poster


presentation )2005 Annual Meeting Of the American Society of Clinical Oncology(ASCO)May 13-17 )orlando,Fl,USA


9-Predictive Factors and Management in Osteosarcoma ;29th congress of Iranian association of surgeon –ISRO annual congress; May 2005


10-Disease-free survival and metastases pattern in breast cancer patients after surgery and adjuvant therapy in Tehran, Iranian application of stratified Markov model(Poster Presentation):17th ICACT ,January 30th ebruary2th,2006,Paris,France
11-Pregnancy and Irradiation: First National Congress of Environment, Occupation and


Cancer in Iran. Oral Presentation, Jun2006, Tehran,Iran
12-Relative Prevalence of Pediatric Cancer at Jorjani Hospital, Tehran.Iran From


1972 to 2001; Iternational Conference o Childhood Cancer;29-31 Oct,2006,Tehran ,Iran 13-New Radiation Therapy Methods in pediatric glial tumors, CNS cancer Congress 2007-


Tehran .Iran
14-Treatment and Prognosis of ovarian cancer in Iran: 5 years, GYN congress, Tehran ,2-4


Feb 2007
15- Heterogeneity in DFS of Breast cancer; International breast cancer CongressTehran,


Iran,23-25 Feb2007
16-Update in head and neck chemoirradiation ISRO congress 2009 17-Management of elderly breast cancer: New criteria for treatment strategy, International breast cancer Congress Tehran,Feb 2009
18- McGill Quality of Life Questionnaire: Reliability and Validity of the Persian Version in Iranian Patients with Advanced Cancer:2th Palliative and supportive care congress ,Tehran, April 2009
19-Our Experience on Impacts of adjuvant Chemotherapy after MRM in terms of DFS ;Oral presentation ;Breast cancer symposium ;Oct 2009 ,Tehran 20-Management Of Metastatic Cancer :Panel Director ;Annual Iranian Association of Cancer Congress ;Tehran Nov 2010
21-Moleculear Pathology in Lung Cancer; Panel Discussion; Annual Pathologists Cancer Congress ;Tehran ;Oct 2011
22- Role of Different Adjuvant Chemotherapy after Surgery in Breast Cancer Patients: Historical Cohort Multi-centric Study ;Poster Presentation ;APCC ,Nov 2011,kulalampour Malaysia
23-Pnelist in Panel discussion ;End of the life issue ;Breast Cancer annually congress Jahad Daneshgahi,2013,Tehran Iran
24-Lecture oral presentation ; Highlights of St Gallen 2013 Updates regarding breast cancer ; annually congress of Iranian association of surgeon –ISRO annual congress, May 2014, Tehran, Iran


And ……..




1-Shahid Fayaz Bakhsh Hospital -Tehran, SSO,


Radiation Oncologist,Onco-geriartician, 2005march, till now
2-Managamant and Performing of medical project and Running of new department (Shafa Teb K co, Iran Pezeshk Co)


2-FFI of Oncology and Radiotherapy Tenon Hospital, Paris France(2007 –2008) 3-FFI of Oncology and Oncogeriatric(Geriatric Department)HEGP Hospital, Paris


France, May 2008-Nov 2008


4. Shohadayee Tagrish Hospital (Shahid Beheshti University),


Radiation Oncology Department (2000- Until 2005)


5. Madaean Hospital, Radiation Oncologist cosultant; Tehran ,Iran( 2000-2007)


6. Membership of Mortality Committee at Shohada Hospital(2001-2004)


7. 3rd Khordad Hospial ,Hemdialysis Section ,Physician and manager , (1994-1995)


8. Shahid Marefizadeh Hospital ,Emergency Room, General Physician , (1993-1994)